MENU
+Compare
PRPH
Stock ticker: NASDAQ
AS OF
Sep 12 closing price
Price
$0.43
Change
-$0.09 (-17.31%)
Capitalization
18.01M

PRPH ProPhase Labs Forecast, Technical & Fundamental Analysis

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing... Show more

PRPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PRPH with price predictions
Sep 12, 2025

PRPH's RSI Oscillator leaves overbought zone

The 10-day RSI Indicator for PRPH moved out of overbought territory on September 12, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 instances where the indicator moved out of the overbought zone. In of the 30 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 54 cases where PRPH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRPH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PRPH broke above its upper Bollinger Band on September 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 03, 2025. You may want to consider a long position or call options on PRPH as a result. In of 106 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PRPH just turned positive on August 20, 2025. Looking at past instances where PRPH's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

PRPH moved above its 50-day moving average on September 08, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PRPH crossed bullishly above the 50-day moving average on September 10, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +4 3-day Advance, the price is estimated to grow further. Considering data from situations where PRPH advanced for three days, in of 276 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 154 cases where PRPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.575) is normal, around the industry mean (24.262). P/E Ratio (0.000) is within average values for comparable stocks, (139.122). PRPH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.692). Dividend Yield (0.000) settles around the average of (0.022) among similar stocks. P/S Ratio (2.361) is also within normal values, averaging (9.748).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PRPH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
PRPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PRPH is expected to report earnings to -10 cents per share on November 06

ProPhase Labs PRPH Stock Earnings Reports
Q3'25
Est.
$-0.11
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.05
Q4'24
Missed
by $1.62
Q3'24
Missed
by $0.04
The last earnings report on August 13 showed earnings per share of -10 cents, beating the estimate of -15 cents. With 5.60M shares outstanding, the current market capitalization sits at 18.01M.
A.I.Advisor
published Dividends

PRPH paid dividends on June 03, 2022

ProPhase Labs PRPH Stock Dividends
А quarterly dividend of $0.30 per share was paid with a record date of June 03, 2022, and an ex-dividend date of May 24, 2022. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of cold remedy products and other supplements

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Household Or Personal Care
Address
711 Stewart Avenue
Phone
+1 215 345-0919
Employees
113
Web
https://www.prophaselabs.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRIO7.110.02
+0.28%
DarioHealth Corp
CAH152.24-0.23
-0.15%
Cardinal Health
CPF30.63-0.29
-0.94%
Central Pacific Financial Corp
PVH81.05-0.97
-1.18%
PVH Corp
HFFG3.22-0.10
-3.01%
HF Foods Group

PRPH and Stocks

Correlation & Price change

A.I.dvisor tells us that PRPH and ANIP have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRPH and ANIP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRPH
1D Price
Change %
PRPH100%
-15.84%
ANIP - PRPH
28%
Poorly correlated
-1.03%
ICCM - PRPH
27%
Poorly correlated
-0.76%
NVST - PRPH
27%
Poorly correlated
-2.78%
FLGT - PRPH
26%
Poorly correlated
-1.66%
SENS - PRPH
23%
Poorly correlated
+1.03%
More